Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Annals of Surgery|September 2, 2005
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trialDonald L Morton, Alistair J Cochran, John F Thompson, et al.The New England Journal of Medicine|September 29, 2006
Sentinel-node biopsy or nodal observation in melanomaDonald L Morton, John F Thompson, Alistair J Cochran, et al.Annals of Surgical Oncology|July 9, 2010
The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)Mark B Faries, John F Thompson, Alistair Cochran, et al.Annals of Surgical Oncology|October 12, 2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma MetastasesMark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, et al.Annals of Internal Medicine|May 6, 2004
Coronary vasomotor abnormalities in insulin-resistant individualsManuel J Quiñones, Miguel Hernandez-Pampaloni, Heinrich Schelbert, et al.Annals of the Rheumatic Diseases|May 9, 2007
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPhilip J Clements, Michael D Roth, Robert Elashoff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiformeAlbert Lai, Anh Tran, Phioanh L Nghiemphu, et al.The New England Journal of Medicine|February 14, 2014
Final trial report of sentinel-node biopsy versus nodal observation in melanomaDonald L Morton, John F Thompson, Alistair J Cochran, et al.Annals of Surgical Oncology|June 1, 2012
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)J Harrison Howard, John F Thompson, Nicola Mozzillo, et al.Neuro-Oncology|March 15, 2014
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacyDavid E Piccioni, Julia Selfridge, Reema R Mody, et al.Pageof 8